Assay of serum allantoin in humans by gas chromatography-mass spectrometry

Clin Chim Acta. 2002 Apr;318(1-2):63-70. doi: 10.1016/s0009-8981(01)00805-1.

Abstract

Background: The small amount of allantoin present in human serum results from free radical (FR) action on urate and may provide a stable marker of free radical activity in vivo. We describe a gas chromatography-mass spectrometry (GC-MS) assay for serum allantoin and report a reference range in healthy individuals.

Methods: Fasting blood samples were obtained from 134 healthy middle-aged volunteers (56 men, mean age 55, range 45-72; 78 women, mean age 55, range 50-72) Allantoin was assayed using 15N(2) allantoin as an internal standard. After isolation from aqueous standards or serum by extraction onto an anion exchange column (AG-MP1), allantoin was derivatised with N-methyl-N-(tert-butyldimethylsilyl) trifluoroacetamide (MTBSTFA). Derivatives were injected onto an HP-1 column and analysed using a Mass Selective Detector with Single Ion Monitoring at 398 and 400 m/z.

Results: The distribution of serum allantoin concentrations in men and women was non-Gaussian and log transformation was used for the analysis of data. Women (10.8 +/- 1.7 micromol/l (mean +/- S.D.)) had significantly lower serum allantoin levels than men (13.4 +/- 1.6 micromol/l, p=0.015). Reference ranges (95% CI) for middle-aged healthy subjects were 7.4-46.8 micromol/l (men) and 3.7-31.2 micromol/l (women).

Conclusion: Gas chromatography-mass spectrometry provides a reliable and accurate method for the determination of serum allantoin.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Allantoin / blood*
  • Arteriosclerosis / blood
  • Biomarkers
  • Calibration
  • Female
  • Free Radicals / metabolism
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Lipids / blood
  • Male
  • Middle Aged
  • Reference Values

Substances

  • Biomarkers
  • Free Radicals
  • Lipids
  • Allantoin